Article Details
Retrieved on: 2022-03-03 23:08:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WuXi STA says its drug product facility in Wuxi City, China has successfully passed its first pre-approval inspection (PAI) and received the GMP ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here